Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study

OBJECTIVES: To compare incidence rates of gastrointestinal (GI) perforations between patients with RA and the general population, and between patients treated with tumour necrosis factor inhibitors (TNFi) and non-TNFi biologics. METHODS: In this nationwide cohort study, a total of 63 532 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbulescu, Andrei, Delcoigne, Bénédicte, Askling, Johan, Frisell, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425111/
https://www.ncbi.nlm.nih.gov/pubmed/32669452
http://dx.doi.org/10.1136/rmdopen-2020-001201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425111/
https://www.ncbi.nlm.nih.gov/pubmed/32669452
http://dx.doi.org/10.1136/rmdopen-2020-001201

Ejemplares similares